English | Español

Amgen Inc.
Jamie Barrand | Feb 24, 2016

Romosozumab decreases spinal fracture risk in postmenopausal women, study indicates
Jamie Barrand | Feb 18, 2016

Anemia therapy study yields positive results
Jamie Barrand | Feb 9, 2016

Third trial of Repatha reveals positive results
Matt Smith | Jan 26, 2016

FDA to review application for Amgen's ABP 501 treatment
Jamie Barrand | Dec 27, 2015

Researchers unveil findings of acute lymphoblastic leukemia therapy trials
Jamie Barrand | Dec 18, 2015

Amgen reacquires rights to three GSK medications
Jamie Barrand | Dec 5, 2015

Amgen submits Marketing Authorization Application for ABP 501 to European Medicines Agency
Jamie Barrand | Oct 16, 2015

Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+ Pharmaceuticals
Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program
+ Pharmaceuticals
Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’